Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Magnus Ohman

Showing results (31-40 of 511) with videos related to

Pageof 52
Sort By:
Circulation. Cardiovascular Interventions|February 18, 2010
Anticoagulant therapy for percutaneous coronary interventionSunil V Rao, E Magnus Ohman
JAMA|August 9, 2022
Balancing the Risks and Benefits of Antiplatelet Therapy After Coronary Artery Bypass Graft SurgerySunil V Rao, E Magnus Ohman
Lancet (London, England)|September 4, 2015
Pharmacological and emerging therapies in the treatment of chronic anginaSteen E Husted, E Magnus Ohman
Circulation|September 10, 2019
Letter by O'Neill and Ohman Regarding Article, "Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock: Matched-Pair IABP-SHOCK II Trial 30-Day Mortality Analysis"William W O'Neill, E Magnus Ohman
The New England Journal of Medicine|November 15, 2011
A new era in secondary prevention after acute coronary syndromeMatthew T Roe, E Magnus Ohman
Annual Review of Medicine|November 28, 2018
Non-Vitamin K Antagonist Oral Anticoagulants in the Treatment of Atrial FibrillationAlexander C Fanaroff, E Magnus Ohman
Circulation. Cardiovascular Interventions|December 20, 2012
Repeat revascularization after PCI: are we reinventing the wheel or redefining Achilles' heel?Wesam A Alhejily, E Magnus Ohman
American Journal of Therapeutics|June 21, 2013
Excess of Solid Cancers After Prasugrel: The Food and Drug Administration OutlookE Magnus Ohman, Matthew T Roe
American Heart Journal|February 28, 2002
Should reperfusion strategies in myocardial infarction be modified for the very elderly?Christopher R Kroll, E Magnus Ohman
American Heart Journal|November 8, 2002
Risk stratification in acute coronary syndromes: the need for continued vigilance in "low-risk" patientsMatthew J Levinsky, E Magnus Ohman
Pageof 52

Showing results (31-40 of 511) with videos related to

Sort By:
Pageof 52
Circulation. Cardiovascular Interventions|February 18, 2010
Anticoagulant therapy for percutaneous coronary interventionSunil V Rao, E Magnus Ohman
JAMA|August 9, 2022
Balancing the Risks and Benefits of Antiplatelet Therapy After Coronary Artery Bypass Graft SurgerySunil V Rao, E Magnus Ohman
Lancet (London, England)|September 4, 2015
Pharmacological and emerging therapies in the treatment of chronic anginaSteen E Husted, E Magnus Ohman
Circulation|September 10, 2019
Letter by O'Neill and Ohman Regarding Article, "Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock: Matched-Pair IABP-SHOCK II Trial 30-Day Mortality Analysis"William W O'Neill, E Magnus Ohman
The New England Journal of Medicine|November 15, 2011
A new era in secondary prevention after acute coronary syndromeMatthew T Roe, E Magnus Ohman
Annual Review of Medicine|November 28, 2018
Non-Vitamin K Antagonist Oral Anticoagulants in the Treatment of Atrial FibrillationAlexander C Fanaroff, E Magnus Ohman
Circulation. Cardiovascular Interventions|December 20, 2012
Repeat revascularization after PCI: are we reinventing the wheel or redefining Achilles' heel?Wesam A Alhejily, E Magnus Ohman
American Journal of Therapeutics|June 21, 2013
Excess of Solid Cancers After Prasugrel: The Food and Drug Administration OutlookE Magnus Ohman, Matthew T Roe
American Heart Journal|February 28, 2002
Should reperfusion strategies in myocardial infarction be modified for the very elderly?Christopher R Kroll, E Magnus Ohman
American Heart Journal|November 8, 2002
Risk stratification in acute coronary syndromes: the need for continued vigilance in "low-risk" patientsMatthew J Levinsky, E Magnus Ohman
Pageof 52